You are here: Industry Insights > fibrosis

News List

AIT Therapeutics to Present High-Dose Nitric Oxide In Vitro Data at the North American Cystic Fibrosis Conference biospectrumasia
October 17, 2018
Press Release AIT Cystic Fibrosis Pulmonary/Respiratory Medicine Clinical Research (R&D) Medical Affairs NACFC
Vivus, diving into the cystic fibrosis sphere, backs stadium step-climbing fundraiser fiercepharma
September 29, 2018
With Pancreaze, a drug for cystic fibrosis patients, Vivus is stepping into an unfamiliar market. So earlier this month, it sponsored a fundraising event to get its name out.
Corbus nets over 600 endocannabinoid-related compounds, planning to develop 1-2 per year fiercebiotech
September 21, 2018
The deal includes $250,000 upfront, plus up to $18.4 million in milestone payments for each compound Corbus develops.
Bristol-Myers Squibb and Nordic Bioscience Announce Collaboration for Fibrosis Biomarker Technology americanpharmaceuticalreview
April 20, 2017
Bristol-Myers Squibb Company and Nordic Bioscience have announced a collaboration agreement to develop biomarker technology to potentially aid in the diagnosis and monitoring of fibrotic diseases including Non-alcoholic steatohepatitis (NASH).
AbbVie’s VIEKIRAX + EXVIERA receives positive opinion for eight-week treatment of GT1b HCV pharmaceutical-technology
March 01, 2017
AbbVie has received a positive opinion for a shorter, eight-week treatment of VIEKIRAX (ombitasvir / paritaprevir / ritonavir tablets) + EXVIERA (dasabuvir tablets).

Previous page 1 2 Next page